Compile Data Set for Download or QSAR
Report error Found 81 Enz. Inhib. hit(s) with all data for entry = 12764
LigandPNGBDBM726434(Entry compound 41: 4- (4-Oxo-2-((2-oxo-2-(thiazol...)
Affinity DataIC50: 51nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726479(Entry compound 96: 2- (((1H-Benzo[d]imidazol-2- ...)
Affinity DataIC50: 100nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630171(CHEMBL5400057 | US12247029, Entry 11)
Affinity DataIC50: 100nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
LigandPNGBDBM50630207(CHEMBL5422933 | US12247029, Entry 1)
Affinity DataIC50: 120nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726471(Entry compound 88: 2- (((1H-Benzo[d]imidazol-2- ...)
Affinity DataIC50: 130nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630209(CHEMBL5438439 | US12247029, Entry 12)
Affinity DataIC50: 130nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630208(CHEMBL5440247 | US12247029, Entry 59)
Affinity DataIC50: 150nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630176(CHEMBL5416390 | US12247029, Entry 65)
Affinity DataIC50: 170nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630182(CHEMBL5414608 | US12247029, Entry 87)
Affinity DataIC50: 170nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726444(Entry compound 55: N- (4-(3-(N- (methylsulfonyl)...)
Affinity DataIC50: 200nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630187(CHEMBL5413402 | US12247029, Entry 95)
Affinity DataIC50: 210nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726465(Entry compound 80: 2- ((3-(4-(N-(5-Methyl-1,3,4- ...)
Affinity DataIC50: 280nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726475(Entry compound 92: trans-Methyl-3-(2-(((1H- benz...)
Affinity DataIC50: 320nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726474(Entry compound 91: trans-Methyl 3-(4-oxo-2- ((2-...)
Affinity DataIC50: 370nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630186(CHEMBL5401086 | US12247029, Entry 44)
Affinity DataIC50: 590nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726458(Entry compound 73: 2- (((3H-Imidazo[4,5-b]pyridin...)
Affinity DataIC50: 610nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726405(Entry compound 6: 2- ((3-(3-Fluorophenethyl)-4- ...)
Affinity DataIC50: 610nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726467(Entry compound 82: 4- (2-(((1H-Benzo[d]imidazol- ...)
Affinity DataIC50: 610nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726466(Entry compound 81: 4 N-Methyl-4-(4-oxo-2-((2- ox...)
Affinity DataIC50: 620nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630200(CHEMBL5408401 | US12247029, Entry 23)
Affinity DataIC50: 760nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630193(CHEMBL5425779 | US12247029, Entry 54)
Affinity DataIC50: 820nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630188(CHEMBL5408172 | US12247029, Entry 4)
Affinity DataIC50: 840nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726459(Entry compound 74: 2- (((6-Bromo-3H-imidazo[4,5- ...)
Affinity DataIC50: 910nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726464(Entry compound 79: 2- (((1H-Benzo[d]imidazol-2- ...)
Affinity DataIC50: 920nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726469(Entry compound 86: 4- (2-(((1H-Benzo[d]imidazol- ...)
Affinity DataIC50: 1.10E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630189(CHEMBL5419458 | US12247029, Entry 8)
Affinity DataIC50: 1.10E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726468(Entry compound 85: 2- ((3-(4-Cyanophenyl)-4-oxo- ...)
Affinity DataIC50: 1.20E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726477(Entry compound 94: tert-Butyl 4-(2-(((1H- benzo[...)
Affinity DataIC50: 1.20E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630202(CHEMBL5415031 | US12247029, Entry 10)
Affinity DataIC50: 1.26E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726442(Entry compound 53: N- (4-(4- (Methylsulfonyl)phe...)
Affinity DataIC50: 1.30E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726453(Entry compound 68: 1,3-Dimethyl-8-(((4-oxo-3- ph...)
Affinity DataIC50: 1.40E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726456(Entry compound 71: 2- (((1-Methyl-4-oxo-4,5- dih...)
Affinity DataIC50: 1.50E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726425(Entry compound 26: N- (4-(3-Fluorophenyl)thiazol-...)
Affinity DataIC50: 1.50E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726408(Entry compound 9: 2- ((4-Oxo-3-(3- (trifluoromet...)
Affinity DataIC50: 1.50E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630183(CHEMBL5415446 | US12247029, Entry 19)
Affinity DataIC50: 1.60E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726472(Entry compound 89: (S)-2-((4-Oxo-3-(1- phenyleth...)
Affinity DataIC50: 1.70E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726401(Entry compound 2: N- (4-(4- (Methylsulfonamido)p...)
Affinity DataIC50: 1.70E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726480(Entry compound 99: trans-2-(((1H- Benzo[d]imidaz...)
Affinity DataIC50: 1.80E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726431(Entry compound 32: 2- ((3-(Furan-2-ylmethyl)-4- ...)
Affinity DataIC50: 1.80E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726452(Entry compound 67: 2- (((4-Oxo-3,4- dihydroquina...)
Affinity DataIC50: 1.90E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630168(CHEMBL5438784 | US12247029, Entry 20)
Affinity DataIC50: 2.00E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726402(Entry compound 3: 2- ((3-(3-Fluorophenethyl)-4- ...)
Affinity DataIC50: 2.10E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630214(CHEMBL5403935 | US12247029, Entry 24)
Affinity DataIC50: 2.20E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726417(Entry compound 18: 2- ((3-(2,2-Difluoro-2- pheny...)
Affinity DataIC50: 2.30E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630205(CHEMBL5421613 | US12247029, Entry 31)
Affinity DataIC50: 2.40E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726460(Entry compound 75: Methyl 2-(((4-oxo-3- phenethy...)
Affinity DataIC50: 2.60E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630170(CHEMBL5419214 | US12247029, Entry 14)
Affinity DataIC50: 2.80E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630203(CHEMBL5437094 | US12247029, Entry 50)
Affinity DataIC50: 2.90E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM726445(Entry compound 56: N- (7-methoxybenzo[d]thiazol- ...)
Affinity DataIC50: 3.10E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM50630159(CHEMBL5402925 | US12247029, Entry 22)
Affinity DataIC50: 3.30E+3nMAssay Description:ADP-Glo kinase assay was performed as described by the manufacturer's protocol. Briefly, the kinase assay was performed with a 5 mixture of liver...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/15/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 81 total ) | Next | Last >>
Jump to: